_version_ 1784852942649556992
author Zieroth, Shelley
Ferrari, Roberto
author_facet Zieroth, Shelley
Ferrari, Roberto
author_sort Zieroth, Shelley
collection PubMed
description
format Online
Article
Text
id pubmed-9762877
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-97628772022-12-20 Time for change Zieroth, Shelley Ferrari, Roberto Eur Heart J Suppl #GDMTWorks: The Race to Initiating and Optimizing HFrEF Therapies Supplement Paper Oxford University Press 2022-12-19 /pmc/articles/PMC9762877/ /pubmed/36545234 http://dx.doi.org/10.1093/eurheartjsupp/suac125 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of the European Society of Cardiology. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle #GDMTWorks: The Race to Initiating and Optimizing HFrEF Therapies Supplement Paper
Zieroth, Shelley
Ferrari, Roberto
Time for change
title Time for change
title_full Time for change
title_fullStr Time for change
title_full_unstemmed Time for change
title_short Time for change
title_sort time for change
topic #GDMTWorks: The Race to Initiating and Optimizing HFrEF Therapies Supplement Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9762877/
https://www.ncbi.nlm.nih.gov/pubmed/36545234
http://dx.doi.org/10.1093/eurheartjsupp/suac125
work_keys_str_mv AT zierothshelley timeforchange
AT ferrariroberto timeforchange